3-(N,O-Dimethylhydroxylaminocarbonyl)benzeneboronic acid pinacol ester
Product Information
Molecular Formula
C15H22BNO4
Description
3-(N,O-Dimethylhydroxylaminocarbonyl)benzeneboronic acid pinacol ester is an extraordinary compound extensively applied in the realm of biomedicine and stands as a pivotal agent in the mitigation of select maladies. Exhibiting an unparalleled molecular configuration, its utility thrives in the realm of synthesizing a myriad of pharmacological interventions, chiefly those tailored to interact with precise enzymes or receptors implicated in ailments such as neoplasms, hyperglycemia, or immune responses.
Synonyms
3-(N,O-Dimethylhydroxylaminocarbonyl)phenylboronic acid, pinacol ester
IUPAC Name
N-methoxy-N-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide
SMILES
B1(OC(C(O1)(C)C)(C)C)C2=CC(=CC=C2)C(=O)N(C)OC
InChI
InChI=1S/C15H22BNO4/c1-14(2)15(3,4)21-16(20-14)12-9-7-8-11(10-12)13(18)17(5)19-6/h7-10H,1-6H3
InChI Key
ATIMPABZLDHDMN-UHFFFAOYSA-N
Melting Point
70-74 °C
Flash Point
Not applicable
Purity
97%
Storage
2-8°C
Computed Properties
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
4
Rotatable Bond Count
3
Exact Mass
291.1641883 g/mol
Monoisotopic Mass
291.1641883 g/mol
Topological Polar Surface Area
48Ų
Heavy Atom Count
21
Formal Charge
0
Complexity
383
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
1
Compound Is Canonicalized
Yes
Patents
| Publication Number | Title | Priority Date |
|---|---|---|
| US-2014018317-A1 | Targeted nitroxide agents | 2011-02-18 |
| US-2016068556-A1 | Targeted nitroxide agents | 2011-02-18 |
| US-9217000-B2 | Targeted nitroxide agents | 2011-02-18 |
| US-9732105-B2 | Targeted nitroxide agents | 2011-02-18 |
| US-2012207687-A1 | Topical formulations of targeted nitroxide agents | 2011-01-14 |
| US-2020000793-A1 | Topical formulations of targeted nitroxide agents | 2011-01-14 |
| US-2014199368-A1 | Intraesophageal administration of targeted nitroxide agents for protection against ionizing irradiation-induced esophagitis | 2010-11-15 |
| US-2019210969-A1 | Intraesophageal administration of targeted nitroxide agents for protection against ionizing irradiation-induced esophagitis | 2010-11-15 |
| EP-2487175-A1 | Pharmaceutical product containing aromatic heterocyclic compound | 2009-10-06 |
| US-2012196854-A1 | Pharmaceutical composition comprising aromatic heterocyclic compound | 2009-10-06 |
